Community Pharmacy England News

- 20TH NOVEMBER 2025
- 0 COMMENTS
National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy
National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy National Patient Safety Alert Reference Number: NatPSA/2025/006/NHSPS Date issued: 20 November 2025 Explanation of identified safety issue There are reports of healthcare staff recording a patient’s penicillin allergy as a penicillamine allergy in electronic prescribing systems. This look-alike sound-alike
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 20TH NOVEMBER 2025
- 0 COMMENTS
MHRA Class 3 Medicines Recall: Fingolimod SUN 0.5mg hard capsules (Sun Pharmaceutical Industries Limited)
MHRA Class 3 Medicines Recall: Fingolimod SUN 0.5mg hard capsules (Sun Pharmaceutical Industries Limited) Drug Alert Number: EL(25)A/49 Date issued: 20 November 2025 Sun Pharma UK Limited is conducting a precautionary recall of a single batch of Fingolimod SUN 0.5 mg hard capsules due to reports of capsule breakage on removing from the blister. No other
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 20TH NOVEMBER 2025
- 0 COMMENTS
APPG report calls for urgent action to unlock the potential of community pharmacy
The All-Party Parliamentary Group (APPG) on Pharmacy has published a new report, The Future of Community Pharmacy in England, recognising the essential and central role that community pharmacies must play in achieving the Government’s ambitions for health and productivity. The report emphasises that community pharmacies are vital to boosting NHS performance, tackling health inequalities, and delivering more care
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 18TH NOVEMBER 2025
- 0 COMMENTS
November 2025 Price Concessions 1st Update
The Department of Health and Social Care (DHSC) has today (18/11/2025) confirmed the following initial list of price concessions for November 2025: Drug Pack size Price concession Co-careldopa 12.5mg/50mg tablets 90 £5.97 Co-careldopa 25mg/100mg tablets 100 £8.26 Febuxostat 80mg tablets 28 £4.09 Fexofenadine 180mg tablets 30 £3.89 Ibandronic acid 150mg tablets 1 £18.40 Latanoprost 50micrograms/ml eye
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 17TH NOVEMBER 2025
- 0 COMMENTS
Medicine Supply Notification: Ibandronic acid 150mg tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ibandronic acid 150mg tablets. Tier 2 – medium impact Date of issue: 17th November 2025 Ibandronic acid 150mg tablets, the only licensed once monthly bisphosphonate, are in limited supply until March 2026. Alendronic acid 70mg tablets and risedronate sodium 35mg tablets
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 12TH NOVEMBER 2025
- 0 COMMENTS
Advance Payments Update: Payments now include Flu and Covid-19 activity
From this month, pharmacy owners may notice a difference in their Advance payments, with these payments higher in value than they have been previously. This is because of a change in policy, with several NHS services now being paid on the same date as the early Advance payment for dispensed prescriptions. Community Pharmacy England has
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 11TH NOVEMBER 2025
- 0 COMMENTS
Morale at breaking point as pharmacy staffing crisis deepens
Community pharmacies across England are facing intense and unsustainable pressure, with morale at breaking point and patient care increasingly at risk, according to findings from Community Pharmacy England’s 2025 Pharmacy Pressures Survey: Staffing and Morale report. With over 4,300 pharmacy premises and 1,600 staff responding, the survey paints a stark picture of a sector grappling
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 11TH NOVEMBER 2025
- 0 COMMENTS
MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited)
MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited) Drug Alert Number: EL(25)A/48 Date issued: 11 November 2025 Sun Pharma UK Limited are recalling the batches of tablets specified in the table as a precautionary measure due to failing dissolution test results reported during ongoing stability studies. DMRC reference number: DMRC
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 10TH NOVEMBER 2025
- 0 COMMENTS
MHRA Class 3 Medicines Recall: Emylif 50mg orodispersible film (Zambon SpA)
MHRA Class 3 Medicines Recall: Emylif 50mg orodispersible film (Zambon SpA) Drug Alert Number: EL(25)A/47 Date issued: 10 November 2025 Zambon SpA is recalling an affected batch as a precautionary measure due to out of specification results for unknown impurities during ongoing stability testing. DMRC reference number: DMRC – 35367036 Marketing Authorisation Holder: Zambon SpA Medicine
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 10TH NOVEMBER 2025
- 0 COMMENTS
Medicine Supply Notification: Propranolol 80mg and 160mg modified release capsules
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Propranolol 80mg modified release capsules Propranolol 160mg modified release capsules MSN/2025/059 Tier 2 – medium impact Date of issue: 10/11/2025 Propranolol 80mg modified release capsules are out of stock until early March 2026. Propranolol 160mg modified release
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News

National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy

MHRA Class 3 Medicines Recall: Fingolimod SUN 0.5mg hard capsules (Sun Pharmaceutical Industries Limited)

APPG report calls for urgent action to unlock the potential of community pharmacy

November 2025 Price Concessions 1st Update

Medicine Supply Notification: Ibandronic acid 150mg tablets

Advance Payments Update: Payments now include Flu and Covid-19 activity

Morale at breaking point as pharmacy staffing crisis deepens

MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited)

MHRA Class 3 Medicines Recall: Emylif 50mg orodispersible film (Zambon SpA)

Medicine Supply Notification: Propranolol 80mg and 160mg modified release capsules

Get in Touch

Working together with key healthcare stakeholders, local councils and other healthcare organisations as necessary to ensure that the provision of pharmaceutical services continues to be an integral part of Health and Social Care